Last reviewed · How we verify

Immucillin H — Competitive Intelligence Brief

Immucillin H (FORODESINE) competitive landscape: 3 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Oncology.

marketed Purine nucleoside phosphorylase Oncology Small molecule Live · refreshed every 30 min

Target snapshot

Immucillin H (FORODESINE) — Mundi Pharma.

Comparator set (3 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Immucillin H TARGET FORODESINE Mundi Pharma marketed Purine nucleoside phosphorylase 2017-01-01
Zovirax ACYCLOVIR Ligand Pharms marketed Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] Purine nucleoside phosphorylase 1982-01-01
Aciclovir Aciclovir Assistance Publique Hopitaux De Marseille marketed Purine nucleoside phosphorylase, DNA polymerase catalytic subunit, Purine nucleoside phosphorylase
ACYC ACYC Ligand Pharms marketed Purine nucleoside phosphorylase, DNA polymerase catalytic subunit, Purine nucleoside phosphorylase

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Immucillin H — Competitive Intelligence Brief. https://druglandscape.com/ci/forodesine. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: